Company Filing History:
6 out of 8 
2 out of 5 
1 out of 48 Years Active: 1999-2019
Title: Nobuko Uchida: Innovator in Oligodendrocyte Research
Introduction
Nobuko Uchida is a prominent inventor based in Palo Alto, CA (US), known for her significant contributions to the field of neuroscience. With a total of 10 patents, she has made remarkable strides in understanding and utilizing oligodendrocyte precursor cells for therapeutic purposes.
Latest Patents
Among her latest patents is a groundbreaking application titled "Target populations of oligodendrocyte precursor cells and methods of making and using same." This invention provides enriched target populations of oligodendrocyte precursor cells (OPCs) that can differentiate into oligodendrocytes. The target OPCs can be expanded and subjected to conditions that induce their differentiation into oligodendrocytes. These cells and their progeny hold promise for treating diseases associated with demyelination of central nervous system axons. Another notable patent is "Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations." This invention offers methods for identifying and isolating neural stem and progenitor cell populations using specific reagents that bind to cell surface markers.
Career Highlights
Nobuko Uchida has had a distinguished career, working with leading organizations in the field. She has been associated with StemCells California, Inc. and StemCells, Inc., where she has contributed to advancing research in stem cell therapies and regenerative medicine.
Collaborations
Throughout her career, Nobuko has collaborated with esteemed colleagues, including Irving L. Weissman and David W. Buck. These collaborations have further enriched her research and innovations in the field.
Conclusion
Nobuko Uchida's work in oligodendrocyte precursor cells and her numerous patents highlight her significant impact on neuroscience and regenerative medicine. Her contributions continue to pave the way for new therapeutic approaches to treat central nervous system diseases.